🔴 Protara Therapeutics is trading 6.9% down

Protara Therapeutics is trading 6.9% lower at $2.84, with no clear company-specific catalyst identified for October 1.

• The latest company release located was the September 8 conference-presentation announcement; no new company-specific announcement was identified for October 1.
• Treasury yields rose sharply, with the 10-year yield reaching 5.33%, its highest level since April 2002. Major indices were down less than 0.5% in the supplied snapshot, so the decline cannot be confidently attributed to market sentiment alone.